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Outcome of cognitive performances 
in bipolar euthymic patients after a depressive 
episode: a longitudinal naturalistic study
Ramona Păunescu* and Ioana Micluţia
Abstract 
Background: Cognitive functions have been investigated across depressed, manic, hypomanic, mixed and euthymic 
episodes of bipolar disorder, but the stability or the progression of cognitive impairment is still under research.
Objective: The purpose of the present study was to assess the outcome of cognitive functions in bipolar patients 
following a depressive episode, after a 6-month period in the absence of mood symptoms.
Method: 63 bipolar patients were tested with a battery of neurocognitive tests both at baseline (during an acute 
depressive episode) and after 6 months of euthymia. The cognitive domains assessed included memory, attention, 
verbal fluency, processing speed and executive functions. Cognitive performances were compared with those of a 
control group (40 healthy control subjects), both in depression and in euthymia.
Results: Patients scored worse than control subjects in several cognitive domains, both in depression and euthymia. 
The most impaired cognitive functions were executive functions and verbal memory. Between the two moments of 
assessment bipolar patients obtained a significant improvement in memory, verbal fluency, attention and information 
processing speed. Psychomotor speed showed no difference between depression and euthymia.
Conclusions: Bipolar patients showed impairment in several cognitive domains during depression. A certain degree 
of impairment remained even after the remission of the affective episode in relationship with the executive functions. 
Between depression and euthymia, bipolar patients showed important cognitive improvements.
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Background
The interest on cognition related to bipolar disorder 
noticed a growing interest during the last decade. Cog-
nitive impairments have been outlined in all acute mood 
episodes of the illness [1–7] but also during euthymic 
phases [8–11].
Data from the literature show impairment in the major-
ity of cognitive areas (attention, memory, verbal fluency, 
set shifting) for patients with bipolar disorder. Among 
these cognitive domains, attention, verbal learning, 
declarative memory, and executive functions were pro-
posed as trait markers for bipolar disorder [12–15].
Attention deficits were highlighted in several studies; 
Torres et  al. [9] concluded that patients with affective 
episodes show performance difficulties in areas related 
to attention which concern visual and motor processing 
speed, accuracy and reaction time at the tasks of main-
taining attention that require identifying targets. Sus-
tained attention or vigilance is impaired in patients with 
bipolar disorder regardless of whether they are evalu-
ated during episodes of mania or depression, as shown in 
the study of Najit et al. [16]. Another study [17] demon-
strated impairment in attention and response inhibition 
(prolonged reaction times and decreased discriminabil-
ity) and also an inability to delay reward within bipolar 
disorder.
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Memory deficits for patients with bipolar disorder 
consist of verbal memory, working memory and visual 
memory impairments [11]. Significant impairment in 
verbal recall and recognition in bipolar depression was 
outlined by Bearden et al. in 2006 [18]. The study of Alt-
shuler et  al. [19] demonstrated lower CVLT (California 
verbal learning test) recall scores for bipolar patients with 
a poorer functioning as well as a relationship between the 
impairment in verbal declarative memory and poor role 
functioning.
Dixon et al. [20] observed a certain pattern of cognitive 
dysfunctions in manic, depressed and euthymic bipolar 
patients in terms of strategic thinking, inhibitory control 
and response initiation regardless of the affective epi-
sode. In a recent review, executive functions, alongside 
with verbal memory were proposed as potential cognitive 
endophenotypes for bipolar disorder [21].
The progression of cognitive impairment has been 
reported by a number of studies [22–24], whereas others 
stress that cognitive impairment is in a strong relation-
ship with acute illness episodes [25, 26].
Methods
63 bipolar patients, both genders, with ages between 18 
and 60 were included into the study. All patients had a 
minimum level of 8  years of education. The patients 
underwent clinical and neurocognitive evaluations twice: 
first time during an acute depressive episode; the second 
time after 6  months of euthymia. The inclusion criteria 
for depressive patients were DSM IV-TR and ICD-10 
diagnosis of Bipolar Disorder and Hamilton Depression 
Rating Scale (HAM-D) >8. For euthymia, inclusion cri-
teria consisted of HAM-D scores <7 and Young Mania 
Rating Scale (YMRS) scores <6. Exclusion criteria were 
chronic alcoholism or any other substance dependence, 
dementia, mental retardation, history of head trauma, or 
any current medical condition which could interfere with 
the level of cognitive performances. Patients were com-
pared to 40 healthy control subjects matched by demo-
graphic characteristics and who met the same exclusion 
criteria. The study was approved by the University of 
Medicine and Pharmacy Iuliu Hatieganu Ethics Commit-
tee and all patients signed an informed consent before 
being admitted in the study.
Demographic and clinical data
Demographic data (age, gender, education level) and 
clinical information (number of previous affective 
episodes, types of previous episodes, history of psy-
chotic symptoms) were collected through the clini-
cal interview and completed with data from medical 
records. First clinical assessment was performed upon 
admission to the hospital for a depressive episode. The 
diagnosis was set according to DSM IV-TR and ICD-
10 diagnosis criteria for bipolar disorder and major 
depressive episode; an additional inclusion crite-
rion was HAM-D score >8. Remission was defined by 
the absence of any affective symptoms for 6  months 
and scores on HAM-D <7 and YMRS <6. Depressive 
patients were recruited while being hospitalized in 
acute emergency wards; therefore, their episodes and 
symptoms were more severe than those of an outpa-
tient population. From baseline to follow-up, all bipo-
lar patients were treated with a combination of 2 or 
3 medications. Thus, 14 patients were treated with a 
combination of antipsychotics and mood stabilizers; 
26 patients were treated with a combination of antip-
sychotics and antidepressants; 23 patients underwent 
treatment with a combination of antipsychotics, mood 
stabilizers and antidepressants.
Neurocognitive assessment
Cognitive functions were assessed using the following 
test batteries: Brief Assessment of Cognition in Schizo-
phrenia (BACS) [27], Trail Making Test A and B (TMT A, 
TMT B) [28] and Wisconsin Card Sorting Test (WCST)-
128 Card Version [29]. Subtests of each battery were used 
to assess specific cognitive domains as follows:
Verbal memory-List learning test (BACS)
Working memory-Digit sequencing test (BACS)
Attention and processing speed
 – Symbol coding test (BACS)
  – Trail Making Test A
Verbal fluency-Category instances test (BACS)
Controlled oral word association test (BACS)
Motor speed-Token motor test (BACS)
Executive functions
 – Tower of London (BACS)
  – Trail Making Test B
  – Total correct trials (WCST)
  – Total errors (WCST)
  – Perseverative errors (WCST)
  – Conceptual levels (WCST)
  – Number of categories completed (WCST)
Statistical analysis
Statistical analysis was performed using IBM Statistical 
Package for Social Sciences 19 (SPPS) software, Windows 
version.
Results
Demographic and clinical characteristics of the patients 
and control group
Bipolar patients and healthy control group were 
matched for all demographic items (gender, age, level 
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of education). Demographic and clinical information is 
summarized in Table 1.
Comparison of cognitive functions between depressed 
patients and control group
The assessment of differences between cognitive perfor-
mances of depressed bipolar patients and healthy con-
trols was performed using Independent Samples t test. 
The equality of variances of the two independent groups 
was analyzed through Levene test. Results are presented 
in Table 2.
Memory
Verbal memory Verbal memory was evaluated with 
List learning—a subtest within BACS battery. Patients 
performed worse than controls (mean score 6.231; 
SD = 2.31958 vs mean score 8.2500; SD = 2.42709), 
obtaining lower total scores for the five consecutive trials 
of the cognitive test.
Working memory The mean score for working memory 
in patients was 15.75 (SD = 5.995) while healthy controls 
obtained a mean score of 18.10 (SD = 6.184). Even if con-
trols scored higher, the difference between the two groups 
had a low statistical significance (p < 0.1).
Attention and information processing speed
Depressed patients and controls obtained similar mean 
scores both for the time of completion in TMT-A (57.70; 
SD  =  24.878 vs 47.10; SD  =  13.608) as well as for the 
total number of trials in symbol coding test (35.22; 
SD = 15.419 vs 42.78; SD = 12.927).
Verbal fluency
For category instances test, the difference between the 
two groups was low (p = 0.026). For the controlled oral 
word association test, the mean for the control group was 
17.45; SD = 7.423 and the mean for patients was 12.92; 
SD = 5.589 (p = 0.001).
Motor speed
The psychomotor speed was tested with the token motor 
test within BACS. Controls performed better with a 
mean score of 82.60 (SD = 10.862) while the mean score 
for patients was 75.89 (SD = 13.272).
Executive functions
Executive functions were assessed with several cognitive 
tests. For Tower of London test within BACS, the differ-
ence between patients and controls was significant for 
the threshold of 5 %. For WCST, we compared raw scores 
for the total number of correct trials, total errors, total 
preservative errors, conceptual levels and the number 
of categories completed. While for the number of total 
correct trials and number of conceptual levels the two 
groups performed similarly (p = 0.184 and p = 0.332), for 
the total number of errors and preservative errors, as well 
as for the number of categories completed, patients per-
formed worse than controls (p < 0.001). For the B version 
of TMT, the differences between the two groups were 
also significant at the threshold of 1  % (p  <  0.001) both 
for the time needed to complete the trial and for the total 
number of errors.
Comparison of mean scores of bipolar patients 
between depression and euthymia
We used paired samples t test to compare the scores 
obtained by bipolar patients between the two times of 
assessment, as presented in Table 3.
Results displayed in Table 3 show that bipolar patients 
obtained significant improvement of cognitive per-
formances between the two moments of assessment 
(depression and euthymia) for the following domains: 
verbal memory (Pearson correlation coefficient = 0.933, 
p  <  0.001), working memory (Pearson correlation coef-
ficient  =  0.854, p  <  0.001), verbal fluency (category 
instances subtest-Pearson correlation coefficient = 0.763; 
p  <  0.001; controlled oral association—Pearson correla-
tion coefficient  =  0.716; p  <  0.05), attention (Pearson 
Table 1 Demographic and clinical data of bipolar group (n = 63) and control group (n = 40)
HAM-D Hamilton Depression Rating Scale, YMRS Young Mania Rating Scale, SD standard deviation
Demographic and clinical aspects Bipolar patients (n = 63) mean/SD Normal controls (n = 40) mean/SD
Age (in years) 48.87 (SD = 12.037) 44.70 (SD = 11.820)
Sex
 1. Male n = 18 (28.57 %) n = 10 (25 %)
 2. Female n = 45 (71.42 %) n = 30 (75 %)
Level of education (years) 11.86 (SD = 3.115) 11.55 (SD = 2.708)
HAM-D scores (depression) 21.17 (SD = 4.324) –
HAM-D scores (euthymia) 4.4603 (SD 1.9823) 3.15 (SD = 2.248)
YMRS scores (euthymia) 1.936 (SD = 1.5102) 1.4 (SD = 1.1047)
Page 4 of 7Păunescu and Micluţia  Ann Gen Psychiatry  (2015) 14:32 
correlation coefficient  =  0.909, p  <  0.05 for TMT-A 
and Pearson correlation coefficient  =  0.887; p  <  0.001 
for symbol coding subtest). Executive functions tested 
with Tower of London test and TMT-B also improved 
between the two moments (Pearson correlation coef-
ficient  =  0.797; p  <  0.01 and Pearson correlation coef-
ficient  =  0.936; p  <  0.001). For WCST there were no 
differences between depression and euthymia for the 
total number of correct trials and conceptual levels 
(p = 0.254; p = 0.056), but the total number of errors and 
preservative errors, as well as the number of categories 
completed improved significantly (p < 0.001). Psychomo-
tor speed did not show significant changes between the 
two moments (Pearson correlation coefficient  =  0.804; 
p = 0.192).
Comparison of mean scores of cognitive assessments 
between euthymic bipolar patients and control
Table  4 shows the differences of cognitive performances 
obtained by the patients after 6  months of euthymia and 
healthy controls. The results show similar performances 
in most cognitive areas. For executive functions assessed 
with TMT-B, the patients obtained significantly lower 
scores than controls (p < 0.001) and had a higher number 
of errors (p = 0.004). The other executive functions scores 
were only significant for a threshold of 5 % (p = 0.030 for 
Tower of London subtest  =  0.013 for WCST-conceptual 
levels). Scores obtained by the control group for verbal flu-
ency and motor speed were also higher than those of the 
patients (p =  0.012 for controlled oral association subtest 
and p = 0.017 for token motor test).
Table 2 Comparison of mean scores of cognitive assessments between depressed bipolar patients and controls
WCST Wisconsin Card Sorting Test, Mean scores mean scores for each group, Std. dev standard deviation, Std. dev error standard deviation error, F F test, Sig significance, 
t t statistic, mean difference Difference between group means, p value probability
Cognitive function Group Mean scores Std. dev Std. dev error F Sig. t Mean difference p value
Memory
 Verbal memory (list learning test) Patients 6.2381 2.31958 0.29224 0.077 0.0782 −4.214 −2.0119 0.000
Control 8.2500 2.42709 0.38376
 Working memory (digit Sequenc-
ing test)
Patients 15.75 5.995 0.755 0.258 0.612 −1.919 −2.354 0.058
Control 18.10 6.184 0.978
Attention and processing speed
 Trail making test A Patients 57.70 24.878 3.134 3.495 0.064 2.467 10.598 0.15
Control 47.10 13.608 2.152
 Symbol coding Patients 35.22 15.419 1.943 0.478 0.491 −2.575 −7.553 0.11
Control 42.78 12.927 2.044
Verbal fluency
 Category instances test Patients 14.67 5.385 0.678 2.474 0.119 −2.259 −2.708 0.026
Control 17.38 6.709 1.061
 Controlled oral word association 
test
Patients 12.92 5.589 0.674 5.152 0.025 −3.568 −4.529 0.001
Control 17.45 7.243 1.126
Motor speed (token motor test) Patients 75.59 13.272 1.672 3.002 0.086 −2.798 −7.013 0.006
Control 82.60 10.862 1.717
Executive functions
 Tower of London Patients 10.84 5.976 0.753 0.569 0.425 −3.123 −3.759 0.002
Control 14.60 5.472 0.865
 Trail making test B Patients 115.02 53.643 6.758 16.174 0.000 4.974 37.066 0.000
Control 77.95 19.845 3.138
 WCST-total correct Patients 75.33 8.910 1.123 0.154 0.695 1.338 21.102 0.184
Control 72.97 8.402 1.328
 WCST-total errors Patients 37.62 16.844 2.122 18.452 0.000 6.442 18.744 0.000
Control 18.88 9.235 1.460
 WCST-preservative errors Patients 20.57 13.102 1.651 25.235 0.000 5.026 10.946 0.000
Control 9.63 5.256 0.831
 WCST-conceptual levels Patients 65.41 6.707 0.845 0.029 0.865 −0.976 −1.287 0.332
Control 66.70 6.227 0.985
 WCST-categories completed Patients 5.40 0.814 0.103 169.397 0.000 6.272 9.348 0.000
Control 6.00 0.000 0.000
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Discussions
Several studies have outlined cognitive impairment in dif-
ferent cognitive domains for bipolar patients. The present 
study is a longitudinal, naturalistic, 6  months follow-up 
study intended to asses the changes of cognitive perfor-
mances in bipolar patients after a depressive episode.
Cognitive functions evaluated during depression 
revealed impairment in several cognitive areas when 
the patients were compared to healthy controls. Verbal 
memory was the most affected function within BACS 
battery (p  <  0.001). Patients group, when compared 
to the controls, recorded a smaller number of words 
recalled for each of the five verbal memory trials. Also, 
the patients group did not show a significant progres-
sion in the number of words remembered after each try, 
unlike the control group, which did. Our findings are 
consistent with those reported by other studies [15, 18, 
30]. There were no important differences between the 2 
groups for working memory. Differences between con-
trols and patients for verbal fluency tests were reported 
to be significant for the threshold of 5  %. While verbal 
fluency was reported as persistently impaired in manic 
episodes [31], data regarding this cognitive domain in 
the depressive phase of bipolar disorder are limited. 
Data from previous studies regarding verbal fluency in 
bipolar disorder are inconsistent. While some research 
showed differences in verbal fluency tasks for bipolar 
patients [32, 33], other found no discrepancy between 
patients with bipolar disorder and control groups [1]. 
Psychomotor speed was assessed with Token motor 
test. Depressive patients performed worse than controls 
(p < 0.05), placing, in total, less tokens and having more 
tokens placed incorrectly. Both tests used for assessing 
attention showed no differences between the depressed 
and control group. For executive functions tests, patient 
performed worse than controls in all measures of assess-
ment. (p  <  0.001 for TMT-B and WCST; p  <  0.05 for 
Tower of London), displaying thus difficulties in set 
shifting, task switching, conceptual skills, planning and 
problem solving.
Repeated measures of cognitive functions after 
6  months showed significant differences for almost all 
cognitive areas. These results may conclude that cog-
nitive impairment could be episode related in bipo-
lar disorder. Both verbal and working memory scores 
improved significantly for remitted patients, who 
obtained similar performances when compared with 
controls (p < 0.001). Attention and verbal fluency were 
also corrected for euthymic patients. Motor speed 
did not improve between the two assessments, sug-
gesting that for this cognitive area, factors other than 
depression are involved. The study of Mora et  al. [34] 
who recruited 28 bipolar patients and 26 controls 
showed the persistence of cognitive impairment in 
areas such as executive functions, inhibition process-
ing speeds and verbal memory which remained affected 
Table 3 Comparison of mean scores of bipolar patients between depression and euthymia
WCST Wisconsin Card Sorting Test, Std. dev standard deviation, CI confidence interval, t t statistic, p value probability
Cognitive function Mean Std. dev 95 % CI t p value
Lower Upper
Memory
 Verbal memory (list learning test) −1.5619 0.88174 −1.2569 −0.81286 −9.316 0.000
 Working Memory (digit sequencing test) −1.603 3.221 −2.414 −0.792 −3.951 0.000
Attention and processing speed
 Trail making test A 3.968 10.400 1.349 6.587 3.029 0.004
 Symbol coding −3.556 7.291 −5.392 −1.719 −3.871 0.000
Verbal fluency
 Category instances test −1.921 3.916 −2.097 −0.934 −3.893 0.000
 Controlled oral word association test −1.095 4.169 −2.145 −0.045 −2.085 0.041
Motor speed (token motor test) −1.333 8.016 −3.352 0.685 −1.320 0.192
Executive functions
 Tower of London −1.254 3.742 −2.196 −0.312 −2.660 0.010
 Trial making test B 9.540 19.384 4.658 14.421 3.906 0.000
 WCST-total correct −0.825 5.695 −2.260 0.609 −1.150 0.254
 WCST-total errors 7.794 4.307 6.709 8.878 14.361 0.000
 WCST-preservative errors 5.365 4.800 4.156 6.574 8.871 0.000
 WCST-conceptual levels −1.571 6.400 −3.183 0.040 −1.949 0.056
 WCST-categories completed −0.349 0.513 −0.478 −0.220 −5.403 0.000
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in bipolar euthymic patients over 6-year follow-up. 
After 6-month follow-up, our study found persistent 
impairment for verbal fluency, processing speed and 
executive functions in euthymic bipolar patients com-
pared to controls. These results are similar to those of 
the study conducted by Torrent et  al. [35] who com-
pared 71 euthymic bipolar patients with 35 controls 
and reported persistent impaired executive functions 
(assessed with WCST and TMT A and B) for bipolar 
euthymic patients. Our results showed that executive 
functions such as cognitive flexibility and set shifting 
assessed with TMT-B improved for euthymic patients 
but remained impaired, when compared to healthy 
controls (p < 0.001).
Conclusions
During a depressive episode bipolar patients show 
impairments in most cognitive areas when compared to 
a healthy control group. After 6  months free of symp-
toms, patients display similar results with controls for 
neurocognitive testing for almost all cognitive functions. 
Executive functions such as the ability to switch between 
tasks and cognitive flexibility remain impaired even dur-
ing euthymia. The results of the present study do not sup-
port the progression of cognitive impairment, showing 
that for the bipolar patients, after 6 months free of symp-
toms, significant improvement is present in most cogni-
tive domains. Nevertheless, all patients included into the 
study were under psychiatric medication, for the entire 
Table 4 Comparison of mean scores of cognitive assessments between euthymic bipolar patients and controls
WCST Wisconsin Card Sorting Test, Mean scores mean scores for each group, Std. dev standard deviation, Std.dev error standard deviation error, F F test, Sig significance, 
t t statistic, Mean difference difference between group means, p value probability
Cognitive function Group Mean scores Std. dev Std. dev error F Sig. t Mean difference p value
Memory
 Verbal memory (list learning test) Patients 7.8000 2.20907 0.27832 0.704 0.404 −0.970 −0.45000 0.335
Control 8.2500 2.42709 0.38376
 Working memory (digit sequencing 
test)
Patients 17.35 5.930 0.747 0.350 0.555 −0.616 −0.751 0.539
Control 18.10 6.184 0.978
Attention and processing speed
 Trail making test A Patients 53.73 21.880 2.757 2.985 0.087 1.716 6.630 0.089
Control 47.10 13.608 2.152
 Symbol coding Patients 38.78 15.286 1.926 0.165 0.685 −1.371 −3.997 0.173
Control 42.78 12.927 2.044
Verbal fluency
 Category instances test Patients 16.59 5.910 0.745 0.913 0.342 −0.625 −0.788 0.533
Control 17.38 6.709 1.061
 Controlled oral word association test Patients 13.45 5.270 0.718 6.926 0.010 −2.569 −3.434 0.012
Control 16.59 7.126 1.126
  Motor speed (token motor test) Patients 76.92 12.058 1.519 1.218 0.272 −2.419 −5.679 0.017
Control 82.60 10.862 1.717
Executive functions
 Tower of London Patients 12.10 5.738 0.723 0.445 0.506 −2.198 −2.505 0.030
Control 14.60 5.472 0.865
 Trail making test B Patients 105.48 45.932 5.787 10.849 0.001 4.182 27.526 0.000
Control 77.95 19.845 3.138
 WCST-total correct Patients 73.75 8.690 1.095 0.044 0.835 0.445 0.771 0.658
Control 72.97 8.402 1.328
 WCST-total errors Patients 22.11 12.988 1.636 4.439 0.038 1.476 3.236 0.143
Control 18.88 9.235 1.460
 WCST-preservative errors Patients 11.40 7.934 1.000 3.983 0.049 1.248 1.772 0.215
Control 9.63 5.256 0.831
 WCST-conceptual levels Patients 66.62 6.015 0.758 0.065 0.799 −0.066 −0.081 0.948
Control 66.70 6.227 0.985
 WCST-categories completed Patients 5.90 0.296 0.037 20.630 0.000 2.555 −0.095 0.013
Control 6.00 0.000 0.000
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duration of the study; therefore, the effect of treatment 
on cognition could have not been ruled out.
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